Skip to content Skip to main menu
MENU
Rob Surgical
CONTACT
  • ENG
    • ESP
    • CAT
Rob Surgical
  • Home
  • About
    • Story
    • Leadership
    • Board Of Directors
    • Testimonials
    • Values
    • Certifications
    • Careers
  • Bitrack System
    • Innovation
    • Characteristics
    • Dynamic Fulcrum Point
    • Hybrid Surgery
    • Open Robotic Platform
    • Instruments
    • Tested
  • Hybrid Surgery
    • Discover the Benefits: Patient
    • Discover the Benefits: Surgeon
    • Discover the Benefits: Hospital
  • Media
  • Contact
  • Market Trends
  • Legal
    • Legal Warning
    • Privacy Policy
    • Cookies Policy
© Rob Surgical 2025. All rights reserved
  • +34 93 013 08 83
  • rss@robsurgical.com
  • Autovia de Castelldefels C-31
  • Km 190-5 (near Airport)
    08820 El Prat de Llobregat (Barcelona)
  • ENG
    • ESP
    • CAT
  • News
  • All
  • Bitrack System
  • Rob Surgical
  • Trends
ROB SURGICAL APPOINTS MARIO FERRADOSA AS GENERAL MANAGER TO LEAD GLOBAL GROWTH, INDUSTRIALIZATION, AND COMMERCIALIZATION
Rob Surgical is entering an exciting new phase as it accelerates toward global commercialization and scale. To lead this next chapter, the company has...
Continue reading ...
July 10, 2025
News
ROB SURGICAL APPOINTS SAMUEL OLIVARES AS COMMERCIAL DIRECTOR
Rob Surgical has announced the appointment of Samuel Olivares as...
Continue reading ...
November 13, 2024
News
ROB SURGICAL, SELECTED TO BE PART OF THE PASS PROGRAM AND INTRODUCE CUTTING-EDGE INNOVATIONS IN THE HEALTH SYSTEM
The Program for Innovation Access to the Health System of...
Continue reading ...
July 30, 2024
News
EXCELLENT RECEPTION OF ROB SURGICAL’S SURGICAL ROBOT AT THE SRS ANNUAL MEETING IN ORLANDO
We have returned from our trip to Orlando and are...
Continue reading ...
June 28, 2024
News
ROB SURGICAL AT THE 2024 SRS ANNUAL MEETING IN ORLANDO
From June 20 to 23, the 2024 SRS Annual Meeting...
Continue reading ...
June 13, 2024
News
ROB SURGICAL IS A FINALIST IN THE SURGICAL ROBOTICS INDUSTRY AWARDS 2024
Surgical Robotics Technology, the leading portal in the robotic surgery...
Continue reading ...
June 3, 2024
News
ROB SURGICAL SUCCESSFULLY CLOSES THE SECOND SERIES OF SURGERIES AT THE HOSPITAL CLÍNIC OF BARCELONA AND FACES THE FINAL PHASE OF EUROPEAN CERTIFICATION
Rob Surgical has announced today the completion of the second...
Continue reading ...
April 8, 2024
News
MANEL BALCELLS, MINISTER OF HEALTH, ATTENDS A SURGERY PERFORMED WITH THE SURGICAL ROBOT OF THE CATALAN COMPANY ROB SURGICAL
The Minister of Health, who was able to meet Bitrack...
Continue reading ...
March 8, 2024
News
LOAD MORE MEDIA
Rob Surgical
  • +34 93 013 08 83
  • rss@robsurgical.com
  • Autovia de Castelldefels C-31
    Km 190-5 (near Airport)
    08820 El Prat de Llobregat (Barcelona)

Sign up to our newsletter

* Required fields:
Data controller: ROB SURGICAL.
Purpose: To manage the sending of electronic newsletters about ROB SURGICAL products, services and activities.
Legitimation: Consent of the data subject.
Recipients: Service providers outside of the European Union that offer appropriate guarantees concerning data protection.
Rights: Access, rectification and erasure, as well as the other rights listed in the additional information section.
Additional information: You can find additional detailed information about how ROB SURGICAL processes your data in the Privacy Policy

You’ve been successfully subscribed to our newsletter!

© 2025 Rob Surgical. All rights reserved Terms and conditions
  • Home
  • About
    • Story
    • Leadership
    • Board Of Directors
    • Testimonials
    • Values
    • Certifications
    • Careers
  • Bitrack System
    • Innovation
    • Characteristics
    • Dynamic Fulcrum Point
    • Hybrid Surgery
    • Open Robotic Platform
    • Instruments
    • Tested
  • Hybrid Surgery
    • Discover the Beneits: Patient
    • Discover the Beneits: Surgeon
    • Discover the Beneits: Hospital
  • Market Trends
  • Contact
  • Media
  • Legal
    • Legal Warning
    • Privacy Policy
    • Cookies Policy
© 2025 Rob Surgical. All rights reserved Terms and conditions